Opioid Management Pilot

The Defense Health Agency (DHA) is exploring options as to how it could best implement a pilot program on Opioid Management in the Military Health System. The pilot program is expected to meet the following requirements: Identification of potential misuse or abuse of opioid medications and opioid potentiators distributed by pharmacies at medical military treatment facilities, retail network pharmacies, and the home delivery pharmacy, as well as the transmission of alerts regarding such potential misuse or abuse of opioids to prescribing physicians and dentists. Direct engagement with, education for, and management of beneficiaries under the TRICARE program to help such beneficiaries avoid misuse or abuse of opioid medications. Proactive outreach by specialist pharmacists to beneficiaries under the TRICARE program when\identifying potential misuse or abuse of opioid medications. Monitoring of beneficiaries under the TRICARE program through the use of predictive analytics to identify the potential for opioid abuse and addiction before beneficiaries begin an opioid prescription. Detection of fraud, waste, and abuse in connection with opioids and opioid potentiators. Identification of and intervention with TRICARE providers who appear to be overprescribing opioids and opioid potentiators See Attachment for additional details.